NYSE - Nasdaq Real Time Price USD

GSK plc (GSK)

40.82

-0.04

(-0.10%)

As of 10:33 AM EDT. Market Open.

UPDATE 2-GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology

GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies' blockbuster COVID-19 vaccines. GSK said in the lawsuit that Pfizer and BioNTech's Comirnaty vaccines violate the company's patent rights in mRNA-vaccine innovations developed "more than a decade before" the outbreak of the COVID-19 pandemic.

Reuters 39 minutes ago

PFE
-2.32%
GSK
-0.10%
BNTX
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology

(Reuters) -GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies' blockbuster COVID-19 vaccines. GSK said in the lawsuit that Pfizer and BioNTech's Comirnaty vaccines violate the company's patent rights in mRNA-vaccine innovations developed "more than a decade before" the outbreak of the COVID-19 pandemic.

Reuters 54 minutes ago

GSK
-0.10%
PFE
-2.32%
BNTX
GSK (GSK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Glaxo (GSK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks yesterday

GSK
-0.10%
10 Best Weight Loss Drug Stocks to Buy Now

In this piece, we will take a look at the ten best weight loss drug stocks to buy now. If you want to skip our introduction to the rising weight loss drug industry and how it’s one of the biggest trends on the stock market right now, then you can take a look at the […]

Insider Monkey 18 days ago

LLY
-1.29%
NVO

VKTX
Health Care Roundup: Market Talk

Read about Agilent Technologies, Novartis, Master Style and more in the latest Market Talks covering the Health Care sector.

The Wall Street Journal 19 days ago

GLAXF

GSK
-0.10%
GSK PLC Sponsored ADR (GSK) is Attracting Investor Attention: Here is What You Should Know

Recently, Zacks.com users have been paying close attention to Glaxo (GSK). This makes it worthwhile to examine what the stock has in store.

Zacks 28 days ago

GSK
-0.10%
UPDATE 1-U.S. FDA approves Akebia's anemia drug

The U.S. Food and Drug Administration approved Akebia Therapeutics' drug, vadadustat, to treat anemia caused by chronic kidney disease (CKD) in dialysis patients, the drugmaker said on Wednesday. The FDA had earlier declined to approve vadadustat - a Hypoxia-inducible factor–prolyl hydroxylase (HIF-PH) inhibitor - on safety concerns, as it posed an increased risk of blood clot formations and drug-induced injuries to the liver.

Reuters 28 days ago

GSK
-0.10%
With 83% ownership of the shares, GSK plc (LON:GSK) is heavily dominated by institutional owners

Key Insights Significantly high institutional ownership implies GSK's stock price is sensitive to their trading actions...

Simply Wall St. last month

GSK
-0.10%
12 Best Biotech Penny Stocks to Invest In

In this article, we discuss the 12 best biotech penny stocks to invest in. If you want to skip our detailed analysis of these stocks, go directly to 5 Best Biotech Penny Stocks to Invest In. The past few years have been a topsy-turvy ride for the biotech sector. There was a massive increase in […]

Insider Monkey last month

ACST

ENTX

CYCN
Billionaires Are Snapping Up Beaten-Down 23andMe Stock. Should You Follow Their Lead?

Several well-regarded funds run by famous billionaire investors bought shares of 23andMe during the last three months of 2023.

Motley Fool last month

ME

GSK
-0.10%
Pfizer to Raise Around $3.5 Billion From Haleon Shares Sale

Pfizer is raising around $3.5 billion from the sale of part of its stake in consumer-healthcare business Haleon

The Wall Street Journal last month

PFE
-2.32%
GLAXF

GSK
-0.10%
Now That Two Inhaler Makers Are Capping Patient Costs, Will More Follow?

AstraZeneca’s move on Monday to cap at $35 the out-of-pocket costs that patients pay for the company’s Symbicort inhaler speaks to the political and regulatory pressure coming to bear on manufacturers of certain commonly used but expensive treatments. The British drugmaker’s shift follows a similar step last month by Boehringer Ingelheim, which sells rival inhalers including Atrovent and Spiriva. Sen. Bernie Sanders, the independent from Vermont, launched an investigation of inhaler prices in January.

The Wall Street Journal last month

GLAXF

GSK
-0.10%
AZN
+5.37%
Positive RUBY phase III data show potential for Jemperli (dostarlimab-gxly) combinations in more patients with primary advanced or recurrent endometrial cancer

PHILADELPHIA, March 16, 2024--RUBY phase III data show potential for Jemperli (dostarlimab-gxly) combinations in more patients with primary advanced or recurrent endometrial cancer

Business Wire last month

GLAXF

GSK
-0.10%
12 Most Profitable Biotech Stocks To Invest In

In this piece, we will take a look at the 12 most profitable biotech stocks to invest in. If you want to skip our overview of the global biotechnology industry and the latest trends, then you can take a look at the 5 Most Profitable Biotech Stocks To Invest In. Biotechnology is the riskiest and […]

Insider Monkey last month

NVO

AZN
+5.37%
ABBV
-0.78%
GSK PLC Sponsored ADR (GSK) Is a Trending Stock: Facts to Know Before Betting on It

Glaxo (GSK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Zacks last month

GSK
-0.10%
The Zacks Analyst Blog Highlights Booz Allen Hamilton, Molson Coors Beverage, Tyson Foods, GlaxoSmithKline and Toyota Motor.

Booz Allen Hamilton, Molson Coors Beverage, Tyson Foods, GlaxoSmithKline and Toyota Motor are part of the Zacks top Analyst Blog.

Zacks last month

GSK
-0.10%
TSN

TM
Inflation Remains Sticky in February: 5 Safe Picks

We have narrowed our search to five low-beta stocks with a solid dividend yield. These are: TAP, TSN, TM, GSK and BAH.

Zacks last month

GSK
-0.10%
TSN

BAH
Has GSK PLC Sponsored ADR (GSK) Outpaced Other Medical Stocks This Year?

Here is how GSK (GSK) and Capricor Therapeutics (CAPR) have performed compared to their sector so far this year.

Zacks last month

CAPR

GSK
-0.10%
10 New Alternatives to Antibiotics: Alternative Therapeutic Strategies to Treat Antibiotic-Resistant Pathogens

In this article, we will be taking a look at 10 new alternatives to antibiotics: alternative therapeutic strategies to treat antibiotic-resistant pathogens. If you do not want to learn about advancements and approaches in global antibiotic market, head straight to the 5 New Alternatives to Antibiotics: Alternative Therapeutic Strategies to Treat Antibiotic-Resistant Pathogens. Exploring new […]

Insider Monkey last month

GSK
-0.10%
MRK
+1.87%
PFE
-2.32%
GSK Doubles COiMMUNITY Grant Funding, Launches Patient Resources, as Adult Vaccination Rates Begin to Show Promising Rise

PHILADELPHIA, March 07, 2024--GSK doubles COiMMUNITY grant funding, launches patient resources, as adult vaccination rates begin to show promising rise

Business Wire last month

GLAXF

GSK
-0.10%

Performance Overview

Return	GSK	FTSE 100
YTD	+11.22%	+4.19%
1-Year	+15.88%	+1.83%
3-Year	+23.34%	+16.12%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

GSK plc (GSK)

UPDATE 2-GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology

GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology

GSK (GSK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

10 Best Weight Loss Drug Stocks to Buy Now

Health Care Roundup: Market Talk

GSK PLC Sponsored ADR (GSK) is Attracting Investor Attention: Here is What You Should Know

UPDATE 1-U.S. FDA approves Akebia's anemia drug

With 83% ownership of the shares, GSK plc (LON:GSK) is heavily dominated by institutional owners

12 Best Biotech Penny Stocks to Invest In

Billionaires Are Snapping Up Beaten-Down 23andMe Stock. Should You Follow Their Lead?

Pfizer to Raise Around $3.5 Billion From Haleon Shares Sale

Now That Two Inhaler Makers Are Capping Patient Costs, Will More Follow?

Positive RUBY phase III data show potential for Jemperli (dostarlimab-gxly) combinations in more patients with primary advanced or recurrent endometrial cancer

12 Most Profitable Biotech Stocks To Invest In

GSK PLC Sponsored ADR (GSK) Is a Trending Stock: Facts to Know Before Betting on It

The Zacks Analyst Blog Highlights Booz Allen Hamilton, Molson Coors Beverage, Tyson Foods, GlaxoSmithKline and Toyota Motor.

Inflation Remains Sticky in February: 5 Safe Picks

Has GSK PLC Sponsored ADR (GSK) Outpaced Other Medical Stocks This Year?

10 New Alternatives to Antibiotics: Alternative Therapeutic Strategies to Treat Antibiotic-Resistant Pathogens

GSK Doubles COiMMUNITY Grant Funding, Launches Patient Resources, as Adult Vaccination Rates Begin to Show Promising Rise

Performance Overview